Supply Chain Management in the Drug Industry

Regular price €109.99
Title
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery

supply-chain management and pharmaceutical industry

A01=Hedley Rees
Author_Hedley Rees
building of a patient value stream
capable processes and suppliers
Category=KJMV8
Category=KND
Category=TDCW
chemistry manufacturing controls
cost effective and risk mitigated pharmaceutical supply chains
drug development and supply-chains
effective flow of information
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_tech-engineering
flexible plant and equipment
reduced waste

shorter cycle times
streamlined logistics
supply of drug
supply-chains in the   pharmaceutical sector
  CMC

Product details

  • ISBN 9780470555170
  • Weight: 780g
  • Dimensions: 164 x 241mm
  • Publication Date: 11 Feb 2011
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: US
  • Product Form: Hardback
Secure checkout Fast Shipping Easy returns
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight – from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.
Hedley Rees runs the independent consulting company Biotech PharmaFlow, which specializes in pharmaceutical supply chain management. He has been actively building, managing, and continuously improving supply chains in biotech for the last fifteen years.

More from this author